These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2427548)

  • 1. Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.
    Johns EA; Turner R; Cooper EH; Maclennan IC
    J Clin Pathol; 1986 Aug; 39(8):833-7. PubMed ID: 2427548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma.
    Coward RA; Delamore IW; Mallick NP; Robinson EL
    Clin Sci (Lond); 1984 Feb; 66(2):229-32. PubMed ID: 6420108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.
    Cooper EH; Forbes MA; Crockson RA; MacLennan IC
    J Clin Pathol; 1984 Aug; 37(8):852-8. PubMed ID: 6206095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary N-acetyl-beta-D-glucosaminidase as an indicator of tubular damage in multiple myeloma.
    Coward RA; DeLamore IW; Mallick NP; Robinson LE
    Clin Chim Acta; 1984 Apr; 138(3):293-8. PubMed ID: 6426824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular proteinuria in myeloma.
    Ballocchi S; Bergonzi G; Dall'Aglio P; Fontana F; Gandi U; Pantano E; Poisetti P; Scarpioni L
    Ric Clin Lab; 1980; 10(1):149-56. PubMed ID: 6781042
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains.
    Melcion C; Mougenot B; Baudouin B; Ronco P; Moulonguet-Doleris L; Vanhille P; Beaufils M; Morel-Maroger L; Verroust P; Richet G
    Clin Nephrol; 1984 Sep; 22(3):138-43. PubMed ID: 6435919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proximal tubular injury in myeloma.
    Batuman V
    Contrib Nephrol; 2007; 153():87-104. PubMed ID: 17075225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure in myelomatosis.
    MacLennan IC; Cooper EH; Chapman CE; Kelly KA; Crockson RA
    Eur J Haematol Suppl; 1989; 51():60-5. PubMed ID: 2516808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light chain crystalline kidney disease: diagnostic urine microscopy as the "liquid kidney biopsy".
    Luciano RL; Castano E; Fogazzi GB; Perazella MA
    Clin Nephrol; 2014 Dec; 82(6):387-91. PubMed ID: 25295579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular and tubular handling of differently charged human immunoglobulin light chains by the rat kidney.
    Baylis C; Falconer-Smith J; Ross B
    Clin Sci (Lond); 1988 Jun; 74(6):639-44. PubMed ID: 3135143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin light chain nephropathies.
    Sturgill BC; Tucker FL; Bolton WK
    Pathol Annu; 1987; 22 Pt 2():133-50. PubMed ID: 3120137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature
.
    Lerner G; Moradi S; Cohen-Bucay A; Chen H; Sanchorawala V; Gordon CE; Henderson JM
    Clin Nephrol; 2020 Apr; 93(4):203-208. PubMed ID: 31907143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular function in multiple myeloma.
    Coward RA; Mallick NP; Delamore IW
    Clin Nephrol; 1985 Oct; 24(4):180-5. PubMed ID: 3933870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.
    Kishi S; Obata F; Miki H; Matsuura M; Nishimura K; Tamaki M; Kishi F; Murakami T; Abe H; Nagai K; Abe M; Doi T
    Intern Med; 2018 Dec; 57(24):3597-3602. PubMed ID: 30101939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal impairment in myeloma: negative association with isoelectric point of excreted Bence-Jones protein.
    Norden AG; Flynn FV; Fulcher LM; Richards JD
    J Clin Pathol; 1989 Jan; 42(1):59-62. PubMed ID: 2466054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of free kappa and lambda light chains in urine by immunoenzyme analysis].
    León VJ; León E; Martínez-Pescador R; López-Borrasca A
    Sangre (Barc); 1986; 31(3):311-6. PubMed ID: 3092374
    [No Abstract]   [Full Text] [Related]  

  • 17. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
    Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
    Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria.
    Honkanen E; Pettersson T; Teppo AM
    Clin Nephrol; 1995 Jul; 44(1):22-7. PubMed ID: 7554529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kidney in myeloma.
    Hamblin TJ
    Br Med J (Clin Res Ed); 1986 Jan; 292(6512):2-3. PubMed ID: 3080049
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point.
    Clyne DH; Pesce AJ; Thompson RE
    Kidney Int; 1979 Sep; 16(3):345-52. PubMed ID: 529681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.